Bdh Industries Ltd. Share Price & Stock Analysis

Bdh Industries Ltd. (BSE: 524828) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹241 Cr, it ranks #2,496 by market cap among the 6,197 Indian listed companies on FinBizNet, and #33 of 63 in Pharmaceuticals. At ₹408.15 (as of 16 Nov 2026), the share price is 33.1% below its 52-week high of ₹610.00 and 20.0% above its 52-week low of ₹340.15. The share price is down 5.0% over one year and down 23.9% over three months.

Key Metrics

Current Price₹408.15
Market Cap₹241 Cr
BSE Code524828
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio22.3
Return on Equity14.84%
Return on Assets8.74%
52-Week Range₹340.15 – ₹610.00
1-Year Price Change-5.0%
3-Month Price Change-23.9%
Beta (1Y)0.09
Dividend Yield1.19%
HeadquartersMumbai, Maharashtra
Websitewww.bdhind.com

Shareholding and Delivery

Delivery averaged 86.1% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Bdh Industries Ltd.

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-ana

Products and Services

1. Pharmaceuticals-This segment engages in the manufacturing of therapeutic formulations covering a range of pharmaceuticals.

Business Segments

1. Pharmaceuticals-99.1% 2. Renewable Energy-0.9%

Bdh Industries Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Bdh Industries Ltd.₹241 Cr22.314.84%—-5.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Bdh Industries Ltd.?

Bdh Industries Ltd. is trading at ₹408.15, with a market capitalisation of ₹241 Cr.

Which sector does Bdh Industries Ltd. belong to?

Bdh Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Bdh Industries Ltd.?

Bdh Industries Ltd. has a P/E of 22.3 and a return on equity of 14.84%.

What is the stock symbol of Bdh Industries Ltd.?

Bdh Industries Ltd. is listed on the BSE under the scrip code 524828.

How has Bdh Industries Ltd.'s share price moved over the past year?

Bdh Industries Ltd.'s share price is down 5.0% over one year and down 23.9% over three months. Its 52-week range is ₹340.15 to ₹610.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.